ArticleNature machine intelligence2026
Sample-efficient generative molecular design using memory manipulation.
Article in Nature machine intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Generative molecular design for drug discovery has recently achieved a wave of experimental validation. Language models operating on string-based representations of molecules are amongst the most successful architectures. The most important factor for downstream success is whether an in silico oracle (computational predictor of a molecule property) is well correlated with the desired end point (such as binding affinity). To this end, current methods use cheaper proxy oracles with a higher throughput before evaluating the most promising subset with high-fidelity oracles. The ability to directly generate molecules with optimal properties as predicted by high-fidelity oracles (computationally expensive simulations with greater predictive accuracy) could greatly enhance generative design and improve hit rates. However, current models are not efficient enough to consider such a prospect, exemplifying the sample efficiency problem. Recently, the Mamba architecture has been proposed as an alternative to transformers, which are widely used in large language models. Existing works have validated Mamba's performance on tasks spanning natural language completion to biology foundation models. In this work, we introduce a framework called Saturn, which demonstrates the application of the Mamba architecture for generative molecular design. Here we elucidate how experience replay with data augmentation improves the sample efficiency and how Mamba intensifies the effect of this mechanism. Next, we show that Mamba with experience replay outperforms 16 models on multiparameter optimization tasks relevant to drug discovery and possesses sufficient sample efficiency to directly optimize density functional theory simulations as a high-fidelity oracle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.